4-(4-chlorophenyl)-N,N-diphenylaniline

We are 4-(4-chlorophenyl)-N,N-diphenylaniline CAS:880800-25-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(4-chlorophenyl)-N,N-diphenylaniline
CAS.NO:880800-25-9
Synonyms:4-chloro-4'-(diphenylamino)biphenyl
[1,1'-Biphenyl]-4-amine,4'-chloro-N,N-diphenyl
Molecular Formula:C24H18ClN
Molecular Weight:355.85900
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

4-(4-chlorophenyl)-N,N-diphenylaniline


Related News: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.bromuro de sodio CAS:7647-15-6 Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.1,4-dichlorobenzene CAS:106-46-7 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.83846-85-9 Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.

Related Products
Product Name
(10-([1,1′:3′,1”-terphenyl]-5′-yl)anthracen-9-yl)boronic acid View Details
4-phenoxyphenol View Details
2,5-Dimethylfuran View Details
2H,4H,5H,6H,7H,7AH-Thieno[3,2-c]pyridin-2-one hydrochloride manufacturer Homopiperazine manufacturer 1,2,3,4-Tetrahydro-9-methylcarbazol-4-one manufacturer 5-fluoropyridine-2-carbonitrile manufacturer 1,1,5,5-Tetramethyl-3,3-diphenyltrisiloxane manufacturer